MONTREAL and CHARLOTTE, N.C., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ending September 30, 2025, and ...

Nasal Spray in Paroxysmal Supraventricular Tachycardia (PSVT) Promotional Launch Plans Set with Quick-Start Capability Upon Potential ...

Drinking 1 cup of caffeinated coffee a day might help lower a person's risk of recurrent AFib episodes by as much as 39%, a ...

Milestone Pharmaceuticals ( ($MIST) ) just unveiled an update. Milestone Pharmaceuticals announced its third-quarter financial results and ...

A study found that drinking at least a cup of caffeinated coffee daily significantly lowered the risk of atrial fibrillation, ...

Over the 3 to 12 months following catheter ablation, patients who received metformin had greater freedom from recurrent ...

People who had a daily cup of coffee had a lower risk of new episodes of atrial fibrillation compared with people who abstained from caffeine.

New research suggests that coffee may be safe for people with irregular heartbeats. Researchers at UCSF tracked 200 adults in the U.S., Canada, and Australia with a history of atrial fibrillation ...

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...

Drinking coffee can protect against atrial fibrillation (A-Fib), a common heart rhythm disorder that causes rapid, irregular ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...